C9orf134 Inhibitors
C9orf134 inhibitors are a diverse class of chemicals that interfere with the protein's function by targeting various signaling pathways. Staurosporine, a broad-spectrum kinase inhibitor, disrupts multiple kinases involved in signal transduction. LY294002 and Wortmannin target phosphoinositide 3-kinases (PI3Ks), potentially hindering C9orf134 via PI3K-dependent pathways. SB203580 and U0126 inhibit p38 MAPK and MEK1/2, respectively, disrupting MAPK signaling pathways linked to C9orf134. Rapamycin inhibits mTOR, blocking mTOR-related processes associated with C9orf134. SP600125 and PD98059 target JNK and MEK, interfering with MAPK pathways. SP0106 inhibits JAK2/STAT3, disrupting potential interactions between C9orf134 and JAK/STAT pathways. GDC-0941 inhibits PI3K, affecting PI3K-dependent signaling linked to C9orf134. SB202190 selectively inhibits p38 MAPK, interfering with C9orf134's potential association with MAPK pathways. Tofacitinib, a JAK inhibitor, disrupts C9orf134 activation by targeting the JAK/STAT pathway. This diverse array of inhibitors highlights the complexity of C9orf134 regulation, offering valuable tools for studying its biological functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor that targets multiple serine/threonine and tyrosine kinases. It disrupts signal transduction pathways, potentially affecting C9orf134 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits phosphoinositide 3-kinases (PI3Ks), pivotal in cellular signaling. Since C9orf134 might be involved in PI3K-related pathways, LY294002 could hinder its activation by disrupting upstream signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK1/2 inhibitor, targeting the mitogen-activated protein kinase kinase (MEK) pathway. Given the potential involvement of C9orf134 in MAPK signaling, U0126 may disrupt its activation by inhibiting MEK1/2. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent and irreversible inhibitor of PI3Ks. As C9orf134 may be linked to PI3K-dependent pathways, Wortmannin could obstruct its activity by suppressing PI3K-mediated signaling events. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 selectively inhibits c-Jun N-terminal kinase (JNK), part of the MAPK family. Given potential interactions between C9orf134 and MAPK pathways, SP600125 can disrupt its function by inhibiting JNK-mediated signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor, disrupting the mammalian target of rapamycin (mTOR) pathway. Considering C9orf134's potential involvement in mTOR-related processes, Rapamycin can hinder its activation by blocking mTOR signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK1 and MEK2, key components of the MAPK/ERK pathway. As C9orf134 may be associated with MAPK signaling, PD98059 can impede its activity by disrupting the MEK-mediated phosphorylation cascade. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $188.00 $199.00 | 2 | |
GDC-0941 inhibits PI3K, targeting the PI3K/AKT/mTOR pathway. Since C9orf134 may be connected to this pathway, GDC-0941 can hinder its activation by disrupting PI3K-dependent signaling, thus influencing downstream events. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB202190 selectively inhibits p38 MAPK. Given the potential association of C9orf134 with MAPK pathways, SB202190 can interfere with its function by blocking the p38 MAPK signaling cascade, preventing downstream effects. | ||||||